Article
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2008
Cerhan James R, Liu-Mares Wen, Fredericksen Zachary S, Novak Anne J, Cunningham Julie M, Kay Neil E, Dogan Ahmet, Liebow Mark, Wang Alice H, Call Timothy G, Habermann Thomas M, Ansell Stephen M, Slager Susan L
Abstract excerpt
Non-Hodgkin's lymphoma (NHL) is a cancer closely associated with immune function, and the tumor necrosis factor (TNF) G-308A promoter polymorphism, which influences immune function and regulation, was recently reported by the InterLymph Consortium to be associated with NHL risk. TNF signaling activates the nuclear factor-kappaB (NF-kappaB) canonical pathway, leading to transcriptional activation of multiple genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
